BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 26172928)

  • 1. Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study.
    Lello S; Sorge R; Surico N;
    Gynecol Endocrinol; 2015; 31(12):992-8. PubMed ID: 26172928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
    Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
    Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the FRAX model for hip fracture predictions in the population-based Kuopio Osteoporosis Risk Factor and Prevention Study (OSTPRE).
    Sund R; Honkanen R; Johansson H; Odén A; McCloskey E; Kanis J; Kröger H
    Calcif Tissue Int; 2014 Jul; 95(1):39-45. PubMed ID: 24792689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Fracture Risk Assessment Tool (FRAX®): applications in clinical practice.
    Watts NB
    J Womens Health (Larchmt); 2011 Apr; 20(4):525-31. PubMed ID: 21438699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probability of fractures predicted by FRAX® and observed incidence in the Spanish ECOSAP Study cohort.
    González-Macías J; Marin F; Vila J; Díez-Pérez A
    Bone; 2012 Jan; 50(1):373-7. PubMed ID: 22129640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-economic comparison of three recommended drugs for the treatment of osteoporosis.
    Brecht JG; Kruse HP; Möhrke W; Oestreich A; Huppertz E
    Int J Clin Pharmacol Res; 2004; 24(1):1-10. PubMed ID: 15575171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
    Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
    J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ten-year fracture risk by FRAX(®) of women with osteoporosis attending osteoporosis care in Hungary].
    Péntek M; Gulácsi L; Tóth E; Baji P; Brodszky V; Horváth C
    Orv Hetil; 2016 Jan; 157(4):146-53. PubMed ID: 26772827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of functioning and assessment of fracture risk of a large Italian osteoporotic population. The Physiatric Approach To Osteoporosis project.
    Gimigliano F; Moretti A; Riccio I; Letizia Mauro G; Gimigliano R; Iolascon G
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):529-38. PubMed ID: 25994371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis among older Saudis: risk of fractures and unmet needs.
    Amin TT; Al Owaifeer A; Al-Hashim H; Alwosaifer A; Alabdulqader M; Al Hulaibi F; Al Hamam A
    Arch Osteoporos; 2013; 8():118. PubMed ID: 23361436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of osteoporotic fractures: a method for setting intervention thresholds.
    Kanis JA; Oden A; Johnell O; Jonsson B; de Laet C; Dawson A
    Osteoporos Int; 2001; 12(5):417-27. PubMed ID: 11444092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison fracture risk calculated by FRAX tool].
    Carranza-Lira S; Lanuza-López MC; Sandoval-Barragán MP
    Ginecol Obstet Mex; 2014 Sep; 82(9):591-4. PubMed ID: 25412552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten-year probability of osteoporotic fracture in 2012 Polish women assessed by FRAX and nomogram by Nguyen et al.-Conformity between methods and their clinical utility.
    Pluskiewicz W; Adamczyk P; Franek E; Leszczynski P; Sewerynek E; Wichrowska H; Napiorkowska L; Kostyk T; Stuss M; Stepien-Klos W; Golba KS; Drozdzowska B
    Bone; 2010 Jun; 46(6):1661-7. PubMed ID: 20156606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia combined with FRAX probabilities improves fracture risk prediction in older Chinese men.
    Yu R; Leung J; Woo J
    J Am Med Dir Assoc; 2014 Dec; 15(12):918-23. PubMed ID: 25262197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation.
    Ray NF; Chan JK; Thamer M; Melton LJ
    J Bone Miner Res; 1997 Jan; 12(1):24-35. PubMed ID: 9240722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of postmenopausal osteoporosis in Germany: estimations from a disease model.
    Gauthier A; Kanis JA; Jiang Y; Dreinhöfer K; Martin M; Compston J; Borgström F; Cooper C; McCloskey E
    Arch Osteoporos; 2012; 7():209-18. PubMed ID: 23196864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors predicting fractures in early postmenopausal women.
    Pfister AK; Welch CA; Emmett MK; Sheets NW
    W V Med J; 2013; 109(3):8-12, 14-5. PubMed ID: 23798274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of osteopenic women at high risk of fracture: the OFELY study.
    Sornay-Rendu E; Munoz F; Garnero P; Duboeuf F; Delmas PD
    J Bone Miner Res; 2005 Oct; 20(10):1813-9. PubMed ID: 16160738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.